Edwards Lifesciences (EW) reported 1.6billioninrevenueforthequarterendedMarch2024,representingayear−over−yearincreaseof9.50.66 for the same period compares to 0.62ayearago.Thereportedrevenuerepresentsasurpriseof+1.431.58 billion. With the consensus EPS estimate being $0.64, the EPS surprise was +3.13%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determ ...